Skip to main content
Top
Published in: CardioVascular and Interventional Radiology 6/2018

01-06-2018 | Laboratory Investigation

Long-Term Implantability of Resorbable Carboxymethyl Cellulose/Chitosan Microspheres in a Rabbit Renal Arterial Embolization Model

Authors: Lihui Weng, Davis Seelig, Omid Souresrafil

Published in: CardioVascular and Interventional Radiology | Issue 6/2018

Login to get access

Abstract

Purpose

To determine the physiologic response to resorbable carboxymethyl cellulose/chitosan (CMC/CN) microspheres in a long-term rabbit model, including the clinical response, gross pathology, and histopathology.

Materials and Methods

Six rabbits were embolized with CMC/CN microspheres (300–500 µm) in one kidney via an inferior renal artery branch. Angiography was performed immediately before and after embolization and prior to killing at 6 months (180 ± 7 days, n = 3) and 12 months (365 ± 10 days, n = 3). A complete necropsy was performed on each animal with dissection of the kidneys and harvesting of additional tissues as per ISO-10993-part 6 and ISO-10993-part 11 guidelines. All tissues were processed and stained for pathological analysis.

Results

The caudal third of target kidneys was successfully embolized with CMC/CN microspheres. Over the course of the study, there were neither notable clinical signs in either embolization group nor significant changes in the tissue/body weight ratio between 6- and 12-month time points. Gross examination revealed that all embolized kidneys had morphologic features consistent with infarction resulted from microsphere delivery. The percentage of infarction decreased from 9.1% ± 5.7% at 6 months to 1.9% ± 0.4% at 12 months. Microscopically, infarcted areas demonstrated evidence of chronic injury and repair, including loss of renal parenchyma with replacement fibrosis, tubular regeneration, and minimal to mild lymphoplasmacytic inflammation without any active changes such as necrosis or neutrophilic inflammation.

Conclusion

No systemic toxicity was observed in the animals 6 and 12 months after CMC/CN microspheres delivery. The local tissue response was mild.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gunn AJ, Sheth RA, Luber B, Huynh MH, Rachamreddy NR, Kalva SP. Predicting outcomes after chemo-embolization in patients with advanced-stage hepatocellular carcinoma: an evaluation of different radiologic response criteria. Cardiovasc Interv Radiol. 2017;40(1):61–8.CrossRef Gunn AJ, Sheth RA, Luber B, Huynh MH, Rachamreddy NR, Kalva SP. Predicting outcomes after chemo-embolization in patients with advanced-stage hepatocellular carcinoma: an evaluation of different radiologic response criteria. Cardiovasc Interv Radiol. 2017;40(1):61–8.CrossRef
2.
go back to reference Zheng L, Shin JH, Han K, Tsauo J, Yoon HK, Ko GY, Shin JS, Sung KB. Transcatheter arterial embolization for gastrointestinal bleeding secondary to gastrointestinal lymphoma. Cardiovasc Interv Radiol. 2016;39(11):1564–72.CrossRef Zheng L, Shin JH, Han K, Tsauo J, Yoon HK, Ko GY, Shin JS, Sung KB. Transcatheter arterial embolization for gastrointestinal bleeding secondary to gastrointestinal lymphoma. Cardiovasc Interv Radiol. 2016;39(11):1564–72.CrossRef
3.
go back to reference Wasser K, Giebel F, Fischbach R, Tesch H, Landwehr P. Transcatheter arterial chemoembolization of colorectal liver metastases using degradable starch microspheres (Spherex®). Own investigations and review to the literature. Radiologe. 2005;45(7):633–43.CrossRefPubMed Wasser K, Giebel F, Fischbach R, Tesch H, Landwehr P. Transcatheter arterial chemoembolization of colorectal liver metastases using degradable starch microspheres (Spherex®). Own investigations and review to the literature. Radiologe. 2005;45(7):633–43.CrossRefPubMed
4.
go back to reference Brown DB, Pilgram TK, Darcy MD, Fundakowski CE, Lisker-Melman M, Chapman WC, et al. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. J Vasc Interv Radiol. 2005;16:1661–6.CrossRefPubMed Brown DB, Pilgram TK, Darcy MD, Fundakowski CE, Lisker-Melman M, Chapman WC, et al. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. J Vasc Interv Radiol. 2005;16:1661–6.CrossRefPubMed
5.
go back to reference Zhou B, Wang J, Yan Z. Ginsenoside Rg3 attenuates hepatoma VEGF overexpression after hepatic artery embolization in an orthotopic transplantation hepatocellular carcinoma rat model. Onco Targets Ther. 2014;7:1945–54.CrossRefPubMedPubMedCentral Zhou B, Wang J, Yan Z. Ginsenoside Rg3 attenuates hepatoma VEGF overexpression after hepatic artery embolization in an orthotopic transplantation hepatocellular carcinoma rat model. Onco Targets Ther. 2014;7:1945–54.CrossRefPubMedPubMedCentral
6.
go back to reference Namur J, Citron SJ, Sellers MT. Embolization of hepatocellular carcinoma with drug–eluting beads: doxorubicin tissue concentration and distribution in patient liver explants. J Hepatol. 2011;55:1332–8.CrossRefPubMed Namur J, Citron SJ, Sellers MT. Embolization of hepatocellular carcinoma with drug–eluting beads: doxorubicin tissue concentration and distribution in patient liver explants. J Hepatol. 2011;55:1332–8.CrossRefPubMed
7.
go back to reference Pieper CC, Meyer C, Vollmar B, Hauenstein K, Schild HH, Wilhelm KE. Temporary arterial embolization of liver parenchyma with degradable starch microspheres (EmboCept®S) in a swine model. Cardiovasc Interv Radiol. 2014;38:435–41.CrossRef Pieper CC, Meyer C, Vollmar B, Hauenstein K, Schild HH, Wilhelm KE. Temporary arterial embolization of liver parenchyma with degradable starch microspheres (EmboCept®S) in a swine model. Cardiovasc Interv Radiol. 2014;38:435–41.CrossRef
8.
go back to reference Kang MJ, Park JM, Choi WS, Lee J, Kwak BK, Lee J. Highly spherical and deformable chitosan microspheres for arterial embolization. Chem Pharm Bull. 2010;58:288–92.CrossRefPubMed Kang MJ, Park JM, Choi WS, Lee J, Kwak BK, Lee J. Highly spherical and deformable chitosan microspheres for arterial embolization. Chem Pharm Bull. 2010;58:288–92.CrossRefPubMed
9.
go back to reference Wang C, Liu J, Gao Q, et al. Preparation and characterization of Pingyangmycin-loaded bovine serum albumin microspheres for embolization therapy. Inter J Pharm. 2007;336:361–6.CrossRef Wang C, Liu J, Gao Q, et al. Preparation and characterization of Pingyangmycin-loaded bovine serum albumin microspheres for embolization therapy. Inter J Pharm. 2007;336:361–6.CrossRef
10.
go back to reference Forster RE, Thürmer F, Wallrapp C, et al. Characterisation of physico-mechanical properties and degradation potential of calcium alginate beads for use in embolization. J Mater Sci Mater Med. 2010;21:2243–51.CrossRefPubMedPubMedCentral Forster RE, Thürmer F, Wallrapp C, et al. Characterisation of physico-mechanical properties and degradation potential of calcium alginate beads for use in embolization. J Mater Sci Mater Med. 2010;21:2243–51.CrossRefPubMedPubMedCentral
11.
go back to reference Flandroy P, Grandfils C, Daenenb B, Snaps F, Dondelinger RF, Jeromeb R. In vivo behavior of poly(d, l)-lactide microspheres designed for chemoembolization. J Control Release. 1997;44:153–70.CrossRef Flandroy P, Grandfils C, Daenenb B, Snaps F, Dondelinger RF, Jeromeb R. In vivo behavior of poly(d, l)-lactide microspheres designed for chemoembolization. J Control Release. 1997;44:153–70.CrossRef
12.
go back to reference Weng L, Rostamzadeh P, Nooryshokry N, Le HC, Golzarian J. In vitro and in vivo evaluation of biodegradable embolic microspheres with tunable anticancer drug release. Acta Biomater. 2013;9:6823–33.CrossRefPubMed Weng L, Rostamzadeh P, Nooryshokry N, Le HC, Golzarian J. In vitro and in vivo evaluation of biodegradable embolic microspheres with tunable anticancer drug release. Acta Biomater. 2013;9:6823–33.CrossRefPubMed
13.
go back to reference Weng L, Rusten M, Talaie R, Hairani M, Rosener NK, Golzarian J. Calibrated bioresorbable microspheres (BRMS): a preliminary study on the level of occlusion and arterial distribution in a rabbit kidney model. J Vasc Interv Radiol. 2013;24(10):1567–75.CrossRefPubMed Weng L, Rusten M, Talaie R, Hairani M, Rosener NK, Golzarian J. Calibrated bioresorbable microspheres (BRMS): a preliminary study on the level of occlusion and arterial distribution in a rabbit kidney model. J Vasc Interv Radiol. 2013;24(10):1567–75.CrossRefPubMed
14.
go back to reference Weng L, Seelig D, Rostamzadeh P, Golzarian J. Calibrated bioresorbable microspheres as an embolic agent: an experimental study in a rabbit renal model. J Vasc Interv Radiol. 2015;26(12):1887–94.CrossRefPubMedPubMedCentral Weng L, Seelig D, Rostamzadeh P, Golzarian J. Calibrated bioresorbable microspheres as an embolic agent: an experimental study in a rabbit renal model. J Vasc Interv Radiol. 2015;26(12):1887–94.CrossRefPubMedPubMedCentral
15.
go back to reference Weng L, Tseng HJ, Rostamzadeh P, Golzarian J. In vitro comparative study of drug loading and delivery properties of bioresorbable microspheres and LC bead. Mater Sci Mater. 2016;27(12):174–82.CrossRef Weng L, Tseng HJ, Rostamzadeh P, Golzarian J. In vitro comparative study of drug loading and delivery properties of bioresorbable microspheres and LC bead. Mater Sci Mater. 2016;27(12):174–82.CrossRef
16.
17.
go back to reference Spiller KL, Anfang RR, Spiller KJ, Ng J, Nakazawa KR, Daulton JW, Vunjak-Novakovic G. The role of macrophage phenotype in vascularization of tissue engineering scaffolds. Biomaterials. 2014;35:4477–88.CrossRefPubMedPubMedCentral Spiller KL, Anfang RR, Spiller KJ, Ng J, Nakazawa KR, Daulton JW, Vunjak-Novakovic G. The role of macrophage phenotype in vascularization of tissue engineering scaffolds. Biomaterials. 2014;35:4477–88.CrossRefPubMedPubMedCentral
18.
go back to reference Anderson JM. Mechanisms of inflammation and infection with implanted devices. Cardiovasc Pathol. 1993;2:33–41.CrossRef Anderson JM. Mechanisms of inflammation and infection with implanted devices. Cardiovasc Pathol. 1993;2:33–41.CrossRef
19.
go back to reference Kumar V, Abbas K, Fausto N, et al. Acute and chronic inflammation. In: Kumar V, Abbas K, Fausto N, et al., editors. Robbins and Cotran pathologic basis of disease. Philadelphia, PA: Saunders; 2010. p. 43–78. Kumar V, Abbas K, Fausto N, et al. Acute and chronic inflammation. In: Kumar V, Abbas K, Fausto N, et al., editors. Robbins and Cotran pathologic basis of disease. Philadelphia, PA: Saunders; 2010. p. 43–78.
20.
go back to reference Anderson JM. Biological responses to materials. Annu Rev Mater Res. 2001;31:81–110.CrossRef Anderson JM. Biological responses to materials. Annu Rev Mater Res. 2001;31:81–110.CrossRef
21.
go back to reference Costa-Pinto AR, Martins AM, Castelhano-Carlos MJ, et al. In vitro degradation and in vivo biocompatibility of chitosan—poly(butylene succinate) fiber mesh scaffolds. J Bioact Compat Polym. 2014;29(2):137–51.CrossRef Costa-Pinto AR, Martins AM, Castelhano-Carlos MJ, et al. In vitro degradation and in vivo biocompatibility of chitosan—poly(butylene succinate) fiber mesh scaffolds. J Bioact Compat Polym. 2014;29(2):137–51.CrossRef
22.
go back to reference Shamekhi MA, Rabiee A, Mirzadeh H, Mahdavi H, Mohebbi-Kalhori D, Baghaban Eslaminejad M. Fabrication and characterization of hydrothermal cross-linked chitosan porous scaffolds for cartilage tissue engineering applications. Mater Sci Eng C Mater Biol Appl. 2017;80:532–42.CrossRefPubMed Shamekhi MA, Rabiee A, Mirzadeh H, Mahdavi H, Mohebbi-Kalhori D, Baghaban Eslaminejad M. Fabrication and characterization of hydrothermal cross-linked chitosan porous scaffolds for cartilage tissue engineering applications. Mater Sci Eng C Mater Biol Appl. 2017;80:532–42.CrossRefPubMed
23.
go back to reference ISO 10993-6:2009. Biological evaluation of medical devices-part 6: tests for local effects after implantation. Geneva: International Organization for Standardization; 2009. ISO 10993-6:2009. Biological evaluation of medical devices-part 6: tests for local effects after implantation. Geneva: International Organization for Standardization; 2009.
24.
go back to reference ISO 10993-11:2009. Biological evaluation of medical devices—part 11: tests for systemic toxicity. Geneva: International Organization for Standardization; 2009. ISO 10993-11:2009. Biological evaluation of medical devices—part 11: tests for systemic toxicity. Geneva: International Organization for Standardization; 2009.
25.
go back to reference Oryan A, Sahvieh S. Effectiveness of chitosan scaffold in skin, bone and cartilage healing. Int J Biol Macromol. 2017;104:1003–11.CrossRefPubMed Oryan A, Sahvieh S. Effectiveness of chitosan scaffold in skin, bone and cartilage healing. Int J Biol Macromol. 2017;104:1003–11.CrossRefPubMed
26.
go back to reference Sainitya AR, Sriram M, Kalyanaraman V, Dhivya S, Saravanan S, Vairamani M, Sastry TP, Selvamurugan N. Scaffolds containing chitosan/carboxymethyl cellulose/mesoporous wollastonite for bone tissue engineering. Int J Biol Macromol. 2015;80:481–8.CrossRefPubMed Sainitya AR, Sriram M, Kalyanaraman V, Dhivya S, Saravanan S, Vairamani M, Sastry TP, Selvamurugan N. Scaffolds containing chitosan/carboxymethyl cellulose/mesoporous wollastonite for bone tissue engineering. Int J Biol Macromol. 2015;80:481–8.CrossRefPubMed
27.
go back to reference Ramli NA, Wong TW. Sodium carboxymethylcellulose scaffolds and their physicochemical effects on partial thickness wound healing. Int J Pharm. 2011;403(1–2):73–82.CrossRefPubMed Ramli NA, Wong TW. Sodium carboxymethylcellulose scaffolds and their physicochemical effects on partial thickness wound healing. Int J Pharm. 2011;403(1–2):73–82.CrossRefPubMed
28.
go back to reference Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20(2):86–100.CrossRefPubMed Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20(2):86–100.CrossRefPubMed
29.
go back to reference Bojar W, Kucharska M, Bubak G, et al. Formation and preclinical evaluation of a new alloplastic injectable bone substitute material. Acta Bioeng Biomech. 2012;14(1):39–44.PubMed Bojar W, Kucharska M, Bubak G, et al. Formation and preclinical evaluation of a new alloplastic injectable bone substitute material. Acta Bioeng Biomech. 2012;14(1):39–44.PubMed
30.
go back to reference Wu HD, Ji DY, Chang WJ, Yang JC, Lee SY. Chitosan-based polyelectrolyte complex scaffolds with antibacterial properties for treating dental bone defects. Mater Sci Eng C. 2012;32:207–14.CrossRef Wu HD, Ji DY, Chang WJ, Yang JC, Lee SY. Chitosan-based polyelectrolyte complex scaffolds with antibacterial properties for treating dental bone defects. Mater Sci Eng C. 2012;32:207–14.CrossRef
31.
go back to reference Aramwit P, Yamdech R, Ampawong S. Controlled release of chitosan and sericin from the microspheres-embedded wound dressing for the prolonged anti-microbial and wound healing efficacy. AAPS J. 2016;18:647–58.CrossRefPubMedPubMedCentral Aramwit P, Yamdech R, Ampawong S. Controlled release of chitosan and sericin from the microspheres-embedded wound dressing for the prolonged anti-microbial and wound healing efficacy. AAPS J. 2016;18:647–58.CrossRefPubMedPubMedCentral
32.
go back to reference Batth KH, Strandberg JD, White R. Long term follow-up of transcatheter embolization with autologous clot, Oxycel and gelfoam in domestic Swine. Invest Radiol. 1977;12:273–80.CrossRef Batth KH, Strandberg JD, White R. Long term follow-up of transcatheter embolization with autologous clot, Oxycel and gelfoam in domestic Swine. Invest Radiol. 1977;12:273–80.CrossRef
Metadata
Title
Long-Term Implantability of Resorbable Carboxymethyl Cellulose/Chitosan Microspheres in a Rabbit Renal Arterial Embolization Model
Authors
Lihui Weng
Davis Seelig
Omid Souresrafil
Publication date
01-06-2018
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 6/2018
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-018-1931-2

Other articles of this Issue 6/2018

CardioVascular and Interventional Radiology 6/2018 Go to the issue